Stay updated on Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays the completed study record for a trial of lirilumab with nivolumab, with or without ipilimumab. It includes eligibility criteria, study arms and outcome measures, locations, reported results, and study documents.
    Difference
    87%
    Check dated 2026-11-11T20:43:11.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-28T21:42:26.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page content.
    Difference
    1%
    Check dated 2026-10-21T22:03:29.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-14T22:06:41.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T22:19:22.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, with the main content replaced by an error message and a Home button. This reflects restricted access to the page rather than an update to the study data or its purpose.
    Difference
    21%
    Check dated 2026-09-23T21:57:55.000Z thumbnail image

Stay in the know with updates to Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.